Literature DB >> 20953852

Sleep apnea in congestive heart failure.

Meredith A Brisco1, Lee R Goldberg.   

Abstract

Obstructive sleep apnea (OSA) is a form of sleep disordered breathing in which pharyngeal muscle relaxation leads to recurrent nighttime apneas and hypopneas that, through increased afterload, intermittent hypoxia, and excess sympathetic activity, weaken the already failing heart. This review presents the current evidence regarding the complex relationship between OSA and heart failure (HF), including support for OSA as both a cause and consequence of HF. The impact of OSA on other cardiovascular diseases, such as hypertension, ischemic heart disease and arrhythmias, as they relate to HF development or exacerbation, also are reviewed.

Entities:  

Mesh:

Year:  2010        PMID: 20953852     DOI: 10.1007/s11897-010-0033-5

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  56 in total

1.  Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure.

Authors:  Kengo Usui; T Douglas Bradley; Jonas Spaak; Clodagh M Ryan; Toshihiko Kubo; Yasuyuki Kaneko; John S Floras
Journal:  J Am Coll Cardiol       Date:  2005-06-21       Impact factor: 24.094

2.  Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation.

Authors:  Apoor S Gami; Dave O Hodge; Regina M Herges; Eric J Olson; Jiri Nykodym; Tomas Kara; Virend K Somers
Journal:  J Am Coll Cardiol       Date:  2007-01-22       Impact factor: 24.094

3.  Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment.

Authors:  N Peled; E G Abinader; G Pillar; D Sharif; P Lavie
Journal:  J Am Coll Cardiol       Date:  1999-11-15       Impact factor: 24.094

4.  Sleep-disordered breathing and coronary artery disease: long-term prognosis.

Authors:  T Mooe; K A Franklin; K Holmström; T Rabben; U Wiklund
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

5.  Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea.

Authors:  W Grimm; J Hoffmann; V Menz; U Köhler; J Heitmann; J H Peter; B Maisch
Journal:  Am J Cardiol       Date:  1996-06-15       Impact factor: 2.778

6.  Influence of obstructive sleep apnea on mortality in patients with heart failure.

Authors:  Hanqiao Wang; John D Parker; Gary E Newton; John S Floras; Susanna Mak; Kuo-Liang Chiu; Pimon Ruttanaumpawan; George Tomlinson; T Douglas Bradley
Journal:  J Am Coll Cardiol       Date:  2007-04-02       Impact factor: 24.094

7.  Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations.

Authors:  S Javaheri; T J Parker; J D Liming; W S Corbett; H Nishiyama; L Wexler; G A Roselle
Journal:  Circulation       Date:  1998-06-02       Impact factor: 29.690

8.  Triggering of nocturnal arrhythmias by sleep-disordered breathing events.

Authors:  Ken Monahan; Amy Storfer-Isser; Reena Mehra; Eyal Shahar; Murray Mittleman; Jeff Rottman; Naresh Punjabi; Mark Sanders; Stuart F Quan; Helaine Resnick; Susan Redline
Journal:  J Am Coll Cardiol       Date:  2009-11-03       Impact factor: 24.094

9.  Obstructive sleep apnea and the recurrence of atrial fibrillation.

Authors:  Ravi Kanagala; Narayana S Murali; Paul A Friedman; Naser M Ammash; Bernard J Gersh; Karla V Ballman; Abu S M Shamsuzzaman; Virend K Somers
Journal:  Circulation       Date:  2003-05-12       Impact factor: 29.690

10.  Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study.

Authors:  Olivier Milleron; Rémy Pillière; Arlette Foucher; Florence de Roquefeuil; Philippe Aegerter; Guillaume Jondeau; Bernadette G Raffestin; Olivier Dubourg
Journal:  Eur Heart J       Date:  2004-05       Impact factor: 29.983

View more
  2 in total

1.  Adiponectin protects rat myocardium against chronic intermittent hypoxia-induced injury via inhibition of endoplasmic reticulum stress.

Authors:  Wenxiao Ding; Xiaofeng Zhang; Hanpeng Huang; Ning Ding; Shijiang Zhang; Sean Z Hutchinson; Xilong Zhang
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

Review 2.  Management of Obstructive Sleep Apnea in Patients With Heart Failure.

Authors:  Youmeng Wang; Christoph Schöbel; Thomas Penzel
Journal:  Front Med (Lausanne)       Date:  2022-02-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.